Clarity Pharmaceuticals Stock Probability of Future Pink Sheet Price Finishing Over 19.67
| CLRPF Stock | 3.89 0.39 11.14% |
Clarity |
Clarity Pharmaceuticals Target Price Odds to finish over 19.67
The tendency of Clarity Pink Sheet price to converge on an average value over time is a known aspect in finance that investors have used since the beginning of the stock market for forecasting. However, many studies suggest that some traded equity instruments are consistently mispriced before traders' demand and supply correct the spread. One possible conclusion to this anomaly is that these stocks have additional risk, for which investors demand compensation in the form of extra returns.
| Current Price | Horizon | Target Price | Odds to move over 19.67 or more in 90 days |
| 3.89 | 90 days | 19.67 | close to zero percent |
Based on a normal probability distribution, the odds of Clarity Pharmaceuticals to move over 19.67 or more in 90 days from now is close to zero percent (This Clarity Pharmaceuticals probability density function shows the probability of Clarity Pink Sheet to fall within a particular range of prices over 90 days) . Probability of Clarity Pharmaceuticals price to stay between its current price of 3.89 and 19.67 at the end of the 90-day period is under 95 .
Assuming the 90 days horizon Clarity Pharmaceuticals has a beta of 0.66 suggesting as returns on the market go up, Clarity Pharmaceuticals average returns are expected to increase less than the benchmark. However, during the bear market, the loss on holding Clarity Pharmaceuticals will be expected to be much smaller as well. Additionally Clarity Pharmaceuticals has a negative alpha, implying that the risk taken by holding this instrument is not justified. The company is significantly underperforming the Dow Jones Industrial. Clarity Pharmaceuticals Price Density |
| Price |
Predictive Modules for Clarity Pharmaceuticals
There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as Clarity Pharmaceuticals. Regardless of method or technology, however, to accurately forecast the pink sheet market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the pink sheet market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.Clarity Pharmaceuticals Risk Indicators
For the most part, the last 10-20 years have been a very volatile time for the stock market. Clarity Pharmaceuticals is not an exception. The market had few large corrections towards the Clarity Pharmaceuticals' value, including both sudden drops in prices as well as massive rallies. These swings have made and broken many portfolios. An investor can limit the violent swings in their portfolio by implementing a hedging strategy designed to limit downside losses. If you hold Clarity Pharmaceuticals, one way to have your portfolio be protected is to always look up for changing volatility and market elasticity of Clarity Pharmaceuticals within the framework of very fundamental risk indicators.α | Alpha over Dow Jones | -0.18 | |
β | Beta against Dow Jones | 0.66 | |
σ | Overall volatility | 0.65 | |
Ir | Information ratio | -0.04 |
Clarity Pharmaceuticals Alerts and Suggestions
In today's market, stock alerts give investors the competitive edge they need to time the market and increase returns. Checking the ongoing alerts of Clarity Pharmaceuticals for significant developments is a great way to find new opportunities for your next move. Suggestions and notifications for Clarity Pharmaceuticals can help investors quickly react to important events or material changes in technical or fundamental conditions and significant headlines that can affect investment decisions.| Clarity Pharmaceuticals generated a negative expected return over the last 90 days | |
| Clarity Pharmaceuticals has high historical volatility and very poor performance |
Clarity Pharmaceuticals Technical Analysis
Clarity Pharmaceuticals' future price can be derived by breaking down and analyzing its technical indicators over time. Clarity Pink Sheet technical analysis helps investors analyze different prices and returns patterns as well as diagnose historical swings to determine the real value of Clarity Pharmaceuticals. In general, you should focus on analyzing Clarity Pink Sheet price patterns and their correlations with different microeconomic environments and drivers.
Clarity Pharmaceuticals Predictive Forecast Models
Clarity Pharmaceuticals' time-series forecasting models is one of many Clarity Pharmaceuticals' pink sheet analysis techniques aimed to predict future share value based on previously observed values. Time-series forecasting models are widely used for non-stationary data. Non-stationary data are called the data whose statistical properties, e.g., the mean and standard deviation, are not constant over time, but instead, these metrics vary over time. This non-stationary Clarity Pharmaceuticals' historical data is usually called time series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the pink sheet market movement and maximize returns from investment trading.
Things to note about Clarity Pharmaceuticals
Checking the ongoing alerts about Clarity Pharmaceuticals for important developments is a great way to find new opportunities for your next move. Our stock alerts and notifications screener for Clarity Pharmaceuticals help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.
| Clarity Pharmaceuticals generated a negative expected return over the last 90 days | |
| Clarity Pharmaceuticals has high historical volatility and very poor performance |